| RS1064796328 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS1064796330 |
MTR
|
Health Risk |
Likely pathogenic |
— |
| RS1064796331 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1064796332 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1064796335 |
OTC
|
Health Risk |
Likely pathogenic |
— |
| RS1064796337 |
ITPR1
|
Health Risk |
Pathogenic |
— |
| RS1064796339 |
ADNP
|
Health Risk |
Pathogenic |
— |
| RS1064796340 |
ANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-hypotonia-spasticity-sleep disorder syndrome, Intellectual disability-hypotonia-spasticity-sleep disorder syndrome |
| RS1064796341 |
COL1A1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796343 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1064796344 |
CASK
|
Health Risk |
Pathogenic/Likely pathogenic |
FG syndrome 4, Syndromic X-linked intellectual disability Najm type |
| RS1064796347 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1064796348 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS1064796350 |
PLP1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796353 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1064796360 |
CCDC39
|
Health Risk |
Pathogenic |
— |
| RS1064796364 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS1064796365 |
KCNQ4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bilateral sensorineural hearing impairment, Bilateral sensorineural hearing impairment |
| RS1064796367 |
DYRK1A
|
Health Risk |
Pathogenic/Likely pathogenic |
DYRK1A-related intellectual disability syndrome, Complex neurodevelopmental disorder |
| RS1064796370 |
HSPB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronopathy, distal hereditary motor |
| RS1064796373 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS1064796375 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1064796377 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 10, Myopathy |
| RS1064796380 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1064796381 |
EFTUD2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796382 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS1064796384 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1064796389 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1064796390 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1064796391 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS1064796394 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1064796397 |
KNL1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796398 |
MRAP
|
Health Risk |
Likely pathogenic |
MRAP-related disorder, MRAP-related disorder |
| RS1064796399 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS1064796402 |
SLC34A3
|
Health Risk |
Pathogenic |
— |
| RS1064796403 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1064796406 |
DYRK1A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Intellectual disability |
| RS1064796407 |
DEAF1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796408 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS1064796409 |
PURA
|
Health Risk |
Likely pathogenic |
— |
| RS1064796410 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1064796411 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS1064796413 |
FGFR2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796415 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS1064796419 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1064796420 |
FOXF1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796421 |
SRD5A3
|
Health Risk |
Pathogenic |
— |
| RS1064796422 |
ABAT
|
Health Risk |
Likely pathogenic |
— |
| RS1064796429 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS1064796433 |
KANSL1
|
Health Risk |
Pathogenic |
— |
| RS1064796434 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1064796435 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064796436 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1064796438 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1064796448 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, idiopathic generalized |
| RS1064796449 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Intellectual disability |
| RS1064796451 |
CDK13
|
Health Risk |
Pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS1064796452 |
FGFR2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796453 |
CTNNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS1064796457 |
CREBBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1064796460 |
TUBA1A
|
Health Risk |
Pathogenic |
Lissencephaly due to TUBA1A mutation, Tubulinopathy |
| RS1064796464 |
CCDC88C
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064796468 |
COL3A1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796469 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
PLA2G6-associated neurodegeneration, PLA2G6-associated neurodegeneration |
| RS1064796470 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS1064796471 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1064796472 |
SON
|
Health Risk |
Pathogenic |
Inborn genetic diseases, ZTTK syndrome |
| RS1064796473 |
MBD5
|
Health Risk |
Likely pathogenic |
— |
| RS1064796474 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1064796476 |
LHCGR
|
Health Risk |
Likely pathogenic |
— |
| RS1064796479 |
RPL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1064796481 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS1064796483 |
MYH3
|
Health Risk |
Likely pathogenic |
— |
| RS1064796486 |
BCS1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease, Neuromuscular disease |
| RS1064796488 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS1064796492 |
NFIA
|
Health Risk |
Likely pathogenic |
— |
| RS1064796494 |
CTNND2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796495 |
MORC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2Z, Charcot-Marie-Tooth disease axonal type 2Z |
| RS1064796496 |
CHD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Developmental and epileptic encephalopathy 94 |
| RS1064796497 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796499 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS1064796500 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS1064796502 |
CLN3
|
Health Risk |
Likely pathogenic |
— |
| RS1064796503 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS1064796508 |
HERC1
|
Health Risk |
Likely pathogenic |
— |
| RS1064796510 |
STIL
|
Health Risk |
Pathogenic |
— |
| RS1064796511 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1064796512 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1064796514 |
GABRB3
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 43 |
| RS1064796516 |
RYR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia, Catecholaminergic polymorphic ventricular tachycardia |
| RS1064796517 |
HDAC8
|
Health Risk |
Likely pathogenic |
— |
| RS1064796522 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS1064796526 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS1064796528 |
SHANK3
|
Health Risk |
Likely pathogenic |
— |
| RS1064796530 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1064796531 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS1064796533 |
SLC6A1
|
Health Risk |
Pathogenic |
— |
| RS1064796535 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1064796538 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS1064796540 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
— |